NTMD will be the next DNDN. Low float samll cap, with one FDA approved drug and has another undertaking. Valueline analyst forecast the new drug will be approved likely, but timing is not certain.
NTMD will be the next DNDN. Low float samll cap, with one FDA approved drug and has another undertaking. Valueline analyst forecast the new drug will be approved likely, but timing is not certain.